149 related articles for article (PubMed ID: 9129219)
1. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
2. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
3. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
4. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia.
Ramsay HM; Fryer AA; Hawley CM; Smith AG; Nicol DL; Harden PN
J Am Acad Dermatol; 2003 Sep; 49(3):397-406. PubMed ID: 12963901
[TBL] [Abstract][Full Text] [Related]
6. Skin cancer in Australian heart transplant recipients.
Ong CS; Keogh AM; Kossard S; Macdonald PS; Spratt PM
J Am Acad Dermatol; 1999 Jan; 40(1):27-34. PubMed ID: 9922009
[TBL] [Abstract][Full Text] [Related]
7. HLA-A11 in renal allograft recipients with skin cancer.
McGregor JM; Reddi G; MacDonald D; Vaughan RW; Welsh KI
J Invest Dermatol; 1992 Feb; 98(2):261-2. PubMed ID: 1571047
[No Abstract] [Full Text] [Related]
8. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
9. Multiple nonmelanoma skin cancer associated with HLA DR7 in southern Australia.
Czarnecki DB; Lewis A; Nicholson I; Tait B
Cancer; 1991 Jul; 68(2):439-40. PubMed ID: 2070340
[No Abstract] [Full Text] [Related]
10. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantation.
Bock A; Bliss RL; Matas A; Little JA
Transplantation; 2004 Sep; 78(5):775-8. PubMed ID: 15371688
[TBL] [Abstract][Full Text] [Related]
12. HLA-A11-associated resistance to skin cancer in renal-transplant recipients.
Bavinck JN; Kootte AM; van der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
N Engl J Med; 1990 Nov; 323(19):1350. PubMed ID: 2215624
[No Abstract] [Full Text] [Related]
13. Cutaneous malignancies in renal transplant recipients from Nova Scotia, Canada.
Dyall-Smith D; Ross JB
Australas J Dermatol; 1995 May; 36(2):79-82. PubMed ID: 7646393
[TBL] [Abstract][Full Text] [Related]
14. Non-melanoma skin cancer risk in the Queensland renal transplant population.
Ramsay HM; Fryer AA; Hawley CM; Smith AG; Harden PN
Br J Dermatol; 2002 Nov; 147(5):950-6. PubMed ID: 12410706
[TBL] [Abstract][Full Text] [Related]
15. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
Bavinck JN; Gissmann L; Claas FH; Van der Woude FJ; Persijn GG; Ter Schegget J; Vermeer BJ; Jochmus I; Müller M; Steger G
J Immunol; 1993 Aug; 151(3):1579-86. PubMed ID: 8393047
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
Iannacone MR; Sinnya S; Pandeya N; Isbel N; Campbell S; Fawcett J; Soyer PH; Ferguson L; Davis M; Whiteman DC; Green AC;
J Invest Dermatol; 2016 Jul; 136(7):1382-1386. PubMed ID: 26968258
[TBL] [Abstract][Full Text] [Related]
17. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
18. Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil.
de Carvalho AV; Bonamigo RR; da Silva CM; Pinto AC
Int J Dermatol; 2012 Dec; 51(12):1448-53. PubMed ID: 23171011
[TBL] [Abstract][Full Text] [Related]
19. Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba.
Bavinck JN; Bastiaens MT; Marugg ME; Beckers RC; Westendorp RG; Vermeer BJ; Claas FH
Arch Dermatol; 2000 Aug; 136(8):1019-22. PubMed ID: 10926738
[TBL] [Abstract][Full Text] [Related]
20. HLA and skin cancer.
Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
